A study published in Engineering shows that a protein called U2 small nuclear RNA auxiliary factor 1 (U2AF1), released by ...

A new study in Engineering reveals how macrophage-released U2AF1 aids heart repair after heart attack by steering Yap1 splicing toward the ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Researchers identified a previously unknown placental molecular process disrupted by gestational diabetes, helping explain ...

Heavy menstrual bleeding triples risk of iron deficiency in teenage girls, Study finds Feeling constantly tired or unfocused ...

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...

TheFly reported on December  16 that Oppenheimer raised its price target on WVE to $32 from $24 while maintaining an ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Scientists are revealing mroe about why TDP-43 has long been linked to the neurodegenerative disorders Alzheimer's, FTD, and ...

Kayode Abidemi John is a pharmacist and a United States-based cancer researcher whose work focuses on prostate cancer at the Graduate School of Biomedical Sciences, University of Texas Health Science ...